Cancer Genetics Inc. shares closed today 16.7% lower than it did at the end of yesterday. The stock is currently up 44.4% year-to-date, down 7.0% over the past 12 months, and down 94.9% over the past five years. Today, the Dow Jones Industrial Average fell 2.0%, and the S&P 500 fell 2.0%. Trading Activity Shares traded as high as $4.80 and as low as $3.49 this week.Shares closed 3e+1% below its 52-week high and 9e+1% above its 52-week low.Trading volume this week was 212.0% higher than the 10-day average and 178.0% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.The stock closed at 0.9% lower than its 5-day moving average, 10.6% higher than its 20-day moving average, and 25.5% higher than its 90-day moving average.
Market Comparative Performance The company's share price lags the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis The company share price lags the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock priceperformance year-to-date beats the peer average by 484.0% The company's stock price performance over the past 12 months lags the peer average by -479.7%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]
© 2020 Kwhen Inc.